250+ investors that invest in your industry and stage
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Finance
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Retail
Infrastructure
Oil and Gas
Fashion
Theatre
Social Impact
Non Profit
Renewable Energy
Sporting Goods
Celebrity
Cryptocurrency
SaaS
Machine Learning
Restaurants
Agriculture (AgTech)
Media (Entertainment)
Facebook
Publishing
Blockchain
Beauty
Real Estate
Life Science
B2B
Film
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Food and Beverage
Social Network
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Nigeria
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Algeria
Romania
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Oman
Guatemala
Cameroon
Colombia
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
United States
New Zealand
Cyprus
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list

Top 50 Biotechnology Angel Investors (June 2026)

The most active angel investors investing in Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
33 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Milad Alucozai
Angel
23 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $110k–$55M
Jeff Dean
Angel
15 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$53M
Paul Buchheit
Angel
12 United States, Canada, India Seed, Series A, Angel Software, E-Commerce, Health Care $100k–$13M
Jude Gomila
Angel
12 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$4.7M
Jaffray Woodriff
Angel
10 United States Seed, Series A, Angel Software, Biotechnology, Health Care $250k–$11M
Kingsley Advani
Angel
9 United States, Singapore, United Kingdom Seed, Pre-Seed, Series A FinTech, Biotechnology, Financial Services $120k–$183M
Farzad Nazem
Angel
9 United States, Canada Seed, Series A, Series B Health Care, Software, Analytics $750k–$50M
Jeff Hammerbacher
Angel
9 United States, Germany Seed, Series A, Angel Software, Artificial Intelligence, Biotechnology $330k–$25M
bumpkins profile
Angel
9 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Robotics $325k–$57M
Sam Altman
Angel
9 United States, Canada, Ghana Seed, Series A, Series B Software, Artificial Intelligence, Internet $1.2M–$100M
Sahin Boydas
Angel
9 United States, Mexico, Norway Seed, Series A, Series B Software, Financial Services, Information Technology $125k–$150M
Jim Mellon
Angel
8 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Health Care $536k–$46M
Balaji Srinivasan
Angel
8 United States, India, Singapore Seed, Series A, Pre-Seed Blockchain, Cryptocurrency, Software $800k–$28M
Alice Zhang
Angel
8 United States, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $120k–$30M
Chris Gibson
Angel
7 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Wei Guo
Angel
7 United States, China, Canada Seed, Series A, Angel Software, Artificial Intelligence, Health Care $200k–$19M
Tim Draper
Angel
6 United States, United Kingdom, Canada Seed, Series A, Series B Software, FinTech, Financial Services $400k–$50M
Cory Levy
Angel
6 United States, Canada, United Kingdom Pre-Seed, Seed, Series A Artificial Intelligence, Software, Advertising $200k–$72M
Bradley Horowitz
Angel
6 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Health Care $150k–$120M
Nadav Rosenberg
Angel
6 United Kingdom, France, Israel Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Software $850k–$19M
Evan Cheng
Angel
6 United States, United Kingdom, Australia Seed, Pre-Seed Software, Artificial Intelligence, Biotechnology $50k–$10M
Zach Weinberg
Angel
6 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, SaaS $1.4M–$30M
Stefano Bernardi
Angel
6 Italy, United Kingdom, France Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $100k–$45M
Erik Peterson
Angel
5 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, Biotechnology, SaaS $69k–$20M
Peter Thiel
Angel
5 United States, Germany, Canada Series A, Seed, Series B Software, FinTech, Financial Services $900k–$105M
Sake Bosch
Angel
5 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.9M–$77M
Brian Armstrong
Angel
5 United States, Brazil Seed, Series A, Series B Payments, Biotechnology, Financial Services $2M–$130M
Mei Z.
Angel
5 United States, United Kingdom, Singapore Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1M–$300M
Alec Nielsen
Angel
5 United States, Germany Seed, Pre-Seed Biotechnology, Biopharma, Medical $3M–$16M
Bhavik Bajaj
Angel
5 United States, Switzerland, United Kingdom Pre-Seed, Seed, Angel Information Technology, Software, FinTech $15k–$3M
Elad Gil
Angel
5 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$100M
Kevin Moore
Angel
5 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $120k–$5.2M
Fred Ehrsam
Angel
5 United States, Canada, Israel Seed, Series A, Series C Blockchain, Cryptocurrency, Software $1M–$300M
Mark Cuban
Angel
5 United States, United Kingdom, Canada Seed, Series A Software, Artificial Intelligence, Blockchain $600k–$23M
Anne Wojcicki
Angel
5 United States, United Kingdom, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$70M
Charlie Songhurst
Angel
5 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $510k–$6.8M
Jan Hammer
Angel
5 China, United States, France Series A, Series B, Seed Health Care, Medical, Medical Device $2.5M–$250M
Daniel Curran
Angel
5 United States, Canada, Brazil Seed, Series A, Series B E-Commerce, Software, Internet $600k–$50M
Todd Corenson
Angel
4 United States Seed, Pre-Seed, Convertible Note Biotechnology, FinTech, SaaS $1M–$4.4M
Bill Gates
Angel
4 United States, Canada, Israel Series C, Series A, Series B Energy, Biotechnology, Manufacturing
Xavier Niel
Angel
4 France, United States, United Kingdom Seed, Series A Software, Artificial Intelligence, SaaS
Martin Chavez
Angel
4 United States, United Kingdom Series A, Seed, Private Equity Health Care, Machine Learning, Biotechnology
Tom Williams
Angel
4 United States, Canada, India Seed, Series A, Series B Software, Health Care, Financial Services
Bernard Majoie
Angel
4 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care
Daren Cotter
Angel
4 United States Seed, Series A Software, E-Commerce, Information Technology
T. Chen Fong
Angel
4 Canada, Singapore, United States Seed, Angel, Pre-Seed Software, Artificial Intelligence, Biotechnology
Penny Schiffer
Angel
4 Switzerland, Germany, United Kingdom Seed, Series A Health Care, Medical, Finance
Annie Vereecken
Angel
4 Belgium Seed, Series A Biotechnology, Medical, Hospital
David Beyer
Angel
4 United States Seed, Series A, Angel Software, Artificial Intelligence, Machine Learning $500k–$23M
Access all 1742 angel investors in Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 33 investments in Biotechnology startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 23 investments in Biotechnology startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 15 investments in Biotechnology startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 87
  • Round size: Seed $2.3M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Altara — Altara is a San Francisco–based startup building a scientific-intelligence AI platform that analyzes complex physical-science and engineering data (batteries, chips, materials, etc.) to speed up R&D and failure analysis.
  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
  • depthfirst — An AI-native security platform that understands your code, business logic, and infrastructure to find more vulnerabilities, slash false positives, and give developers actionable fixes in their workflow.
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 12 investments in Biotechnology startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 152
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 12 investments in Biotechnology startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

Jaffray Woodriff
Angel · Charlottesville, Virginia, United States · 10 investments in Biotechnology startups

Angel Investor located in Charlottesville, VA

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 47
  • Round size: Seed $640k–$4.3M; Angel $250k–$2.6M; Series A $3.4M–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
  • Knit — Knit helps researchers run agency-quality quant + qual research at DIY costs, by taking the most time-intensive research tasks off their plate through Researcher-Driven AI.
  • Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
Show all investments...

Kingsley Advani
Angel · San Francisco, California, United States · 9 investments in Biotechnology startups

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

Show more...

Investment focus

  • Industry: FinTech, Biotechnology, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 45
  • Round size: Seed $120k–$4.3M; Pre-Seed $120k–$4.5M; Series A $4M–$183M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Orbit Fab — Orbit Fab is creating the future of on-orbit satellite refueling. We maximize your operational assets by enabling mission flexibility and freedom of action in space.
  • Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
  • Volumetric — Advanced materials and 3D biofabrication.
Show all investments...

Farzad Nazem
Angel · Palo Alto, California, United States · 9 investments in Biotechnology startups

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Show more...

Investment focus

  • Industry: Health Care, Software, Analytics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 64
  • Round size: Seed $750k–$6.5M; Series A $2.8M–$14M; Series B $6M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the leading AI-powered graph database. Uncover hidden relationships, run real-time analytics at scale, and power fraud detection, customer 360, and AI
Show all investments...

Jeff Hammerbacher
Angel · 9 investments in Biotechnology startups

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Vectara — Trusted AI Agents, Zero Compromises
  • Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
  • Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
Show all investments...

bumpkins profile
Angel · 9 investments in Biotechnology startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Robotics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
  • Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sam Altman
Angel · San Francisco, California, United States · 9 investments in Biotechnology startups

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Ghana

Investor stats

  • Total investments: 177
  • Round size: Seed $1.2M–$10M; Series A $6M–$70M; Series B $17M–$100M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
  • BRINC Drones — BRINC is a US company developing tech in the service of public safety. Known for Drone as First Responder, indoor tactical drones and more.
  • NOYACK — NOYACK builds agentic AI technology for wealth management, starting with NOYACK.ai—the first AI agent for financial literacy - and Prophit.ai , the first opensource AI agent for portfolio optimizations of ALL asset classes. The fintech platform uses autonomous AI to deliver personalized financial guidance and construct tax-optimized portfolioscombining traditional accounts (IRAs, 401(k)s, HSAs) with private market investments in venture capital, fine art, and real estate for Millennials and Gen Z investors
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 9 investments in Biotechnology startups

Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Financial Services, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Mexico, Norway

Investor stats

  • Total investments: 151
  • Round size: Seed $125k–$34M; Series A $6M–$25M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Polymarket — Bet on your beliefs
  • Machina Labs — Machina Labs is an advanced manufacturing company using next-gen AI and robotics technologies to build software-defined factories of the future.
  • Harbinger — Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans.
Show all investments...

Jim Mellon
Angel · 8 investments in Biotechnology startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 32
  • Round size: Seed $536k–$20M; Series A $4.6M–$46M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • OncoSenX — OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease.
  • Netwealth — Netwealth provides expert investment management and tailored wealth planning solutions, helping you confidently achieve your financial goals.
  • Repair Biotechnologies — Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself.
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 8 investments in Biotechnology startups

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 234
  • Round size: Seed $2.3M–$15M; Pre-Seed $800k–$4.2M; Series A $6M–$28M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
  • Parallax — Parallax offers a cross-border payments platform for freelancers, remote workers, and businesses. The service enables receiving international client payments, holding funds in USD, exchanging currencies, and sending money to domestic bank accounts and mobile wallets. Users manage balances and transfers through a web app with quoted rates anditemized fees. The platform supports global payouts and recurring disbursements to partners and team members. Compliance measures include identity verification and transaction monitoring aligned with regulatory standards. Documentation and support resources guide account setup, funding, and cash-out.
  • Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Show all investments...

Alice Zhang
Angel · San Francisco, California, United States · 8 investments in Biotechnology startups

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $120k–$5.9M; Series A $12M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 7 investments in Biotechnology startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Inato — Inato matches the right sites to the right clinical research study, globally.
  • Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Wei Guo
Angel · San Francisco, California, United States · 7 investments in Biotechnology startups

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 153
  • Round size: Seed $200k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
  • Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
  • Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.
Show all investments...

Tim Draper
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 281
  • Round size: Seed $400k–$5.8M; Series A $2.5M–$25M; Series B $3M–$50M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • GALY — GALY biocrafts premium cocoa and cotton with quality, traceability, and scalable supply for modern brands.
  • Buupass — BuuPass is Kenya's market leader for online bus booking. We enable travelers to reserve seats and make payments in a convenient and timely way. Try BuuPass today!
  • Vivoo — Get personalized wellness insights with Vivoo's innovative, science-backed products. Understand your body's needs and take control of your body. Shop now!
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Advertising
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $1.6M–$15M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Wander — Never book a bad vacation home again. Every Wander comes with hotel-grade amenities, inspiring views, pristine cleaning and 24/7 concierge service.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
  • Swish Robotics — Embodied Intelligence for the Home
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 6 investments in Biotechnology startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 113
  • Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Opal — Making it better at capturing incredible low-light video. Even in dimly lit room, you’ll get a level of detail and color that wasn’t possible before.The Opal C1 comes with MicMesh™, an array of beamforming microphones that find and focus on the sound of your voice. And with intelligent noise cancellation, every ding, drop and dog bark is filteredout to get an audio experience that clearly speaks for itself.
  • Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nadav Rosenberg
Angel · London, England, United Kingdom · 6 investments in Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Show all investments...

Evan Cheng
Angel · Burlingame, California, United States · 6 investments in Biotechnology startups

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, Australia

Investor stats

  • Total investments: 25
  • Round size: Seed $50k–$5M; Pre-Seed $150k–$10M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jarsy — Jarsy Inc offers a platform for global investment opportunities using stablecoins.
  • PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
  • Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 6 investments in Biotechnology startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$6.3M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
  • Nym — Nym Health leverages advanced AI for medical coding, revolutionizing accuracy and speed within revenue cycle management. Discover the difference.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 5 investments in Biotechnology startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 60
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Peter Thiel
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 211
  • Round size: Seed $900k–$8.5M; Series A $3M–$32M; Series B $16M–$105M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
  • Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
  • Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 5 investments in Biotechnology startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 31
  • Round size: Seed $1.9M–$9.5M; Series A $6.9M–$29M; Series B $7.1M–$77M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • LionVolt — LionVolt is a battery startup company that claims to develop the most efficient solid state lithium-ion battery.
  • Fairbrics — Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market.
  • Multus — Key ingredients for the affordable scale-up of cellular agriculture
Show all investments...

Brian Armstrong
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Show more...

Investment focus

  • Industry: Payments, Biotechnology, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Brazil

Investor stats

  • Total investments: 16
  • Round size: Seed $2M–$12M; Series A $13M–$25M; Series B $45M–$130M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
  • Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
  • Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.
Show all investments...

Mei Z.
Angel · San Francisco Bay Area, California, United States · 5 investments in Biotechnology startups

Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 31
  • Round size: Seed $4M–$300M; Pre-Seed $1M–$11M; Series A $17M–$155M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Coframe — Transform your website with AI-driven optimization and personalization that boosts engagement and conversions. Coframe automates growth 24/7.
  • Harmonyze — Harmonyze transforms fragmented franchise operations data into clear, daily, revenue-boosting recommendations with AI-powered coaching.
  • Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Show all investments...

Alec Nielsen
Angel · Cambridge, Massachusetts, United States · 5 investments in Biotechnology startups

Alec Nielsen is the Founder & CEO at Asimov.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $3M–$16M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
  • Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
  • General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Bhavik Bajaj
Angel · 5 investments in Biotechnology startups

Bhavik Bajaj

Show more...

Investment focus

  • Industry: Information Technology, Software, FinTech
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 74
  • Round size: Seed $100k–$3M; Angel $15k–$1.6M; Pre-Seed $43k–$1.3M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
  • ORA Technologies — E-Commerce, Super App
  • THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 235
  • Round size: Seed $2M–$15M; Series A $9.5M–$50M; Series B $28M–$100M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Petual — Petual is building the AI-powered platform for audit and compliance, transforming how enterprises manage SOX, operational, financial, and compliance risk. Our intelligent agents deliver precision, coverage, and speed impossible with manual testing.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Decagon — Trusted by world-class companies, Decagon is the most advanced AI platform for customer support.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 5 investments in Biotechnology startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 99
  • Round size: Seed $190k–$5.2M; Pre-Seed $120k–$3.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VantedgeAI — Fine-tuned AI models for scaling credit investing workflows, reducing analysis time and costs by up to 10x, and setting a new standard in rapid, cost-effective deal analysis and monitoring with initial focus on MBS, ABS, CLOs, etc.
  • Binarly — Binarly is the world's most advanced automated firmware supply chain security platform. Using cutting-edge machine-learning techniques, Binary identifies both known and unknown vulnerabilities, misconfigurations, and malicious code in firmware and hardware components.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Show all investments...

Fred Ehrsam
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Fred Ehrsam is the Co-Founder of Paradigm.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Series A, Series C
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 54
  • Round size: Seed $1M–$12M; Series A $7M–$45M; Series C $65M–$300M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
  • Wispr Flow — Wispr AI is a developer of the next-generation of neural interfaces to provide seamless interface with immersive technology. The company is working with the leading neuroscientist, hardware engineers, machine learning researchers, and product engineers to bring frontier technology to the mass consumer market.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Show all investments...

Mark Cuban
Angel · Dallas, Texas, United States · 5 investments in Biotechnology startups

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Blockchain
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 186
  • Round size: Seed $600k–$9M; Series A $3.2M–$23M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • ESAI — ESAI is the viral storytelling platform for Gen Z college applicants and young professionals.
  • Yendo — Our mission is to provide everyone with the most accessible, most affordable, and most transparent credit by leveraging their vehicles.
  • Polygon — Polygon is the most proven way to build and scale your decentralized application and projects on Ethereum, the world's largest blockchain ecosystem.
Show all investments...

Anne Wojcicki
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 59
  • Round size: Seed $1M–$12M; Series A $7M–$70M; Series B $17M–$60M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
  • Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
  • Endo Health — Reverse Your Diabetes With a Game
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 5 investments in Biotechnology startups

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 177
  • Round size: Seed $1.1M–$6.8M; Pre-Seed $510k–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
  • Hyphen SCS — Find and rent verified warehouses across 992+ cities in India. Compare 65,000+ listings on Hyphen SCS.
  • Interface — Interface is an AI-native Document Management System for High Hazard Industries.
Show all investments...

Jan Hammer
Angel · London, England, United Kingdom · 5 investments in Biotechnology startups

Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, France

Investor stats

  • Total investments: 72
  • Round size: Seed $2.5M–$15M; Series A $2.8M–$50M; Series B $14M–$250M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Sofía — Improving the way millions of people take care of their health
  • Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Show all investments...

Daniel Curran
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Daniel Curran is the Founder and CEO at CustEx.com.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Brazil

Investor stats

  • Total investments: 145
  • Round size: Seed $600k–$5M; Series A $3.6M–$23M; Series B $2.3M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
  • Shred Video — Shred Video, a new startup launching out of Y Combinator, allows users to take footage from their iPhone, GoPro or drone and simply match it with a song from the user’s iTunes library. That’s all. Shred Video does the rest of the work.Taking into account the acceleration of the camera itself, Shred Video can pin-point the moments of action forsurfers, snowboarders, skaters and other acceleration-based sports to highlight all of the coolest clips in your footage. And beyond that, Shred Video matches those epic moments with the beat-drop of the song.
  • GC Plus — Find Your Next Home Service Expert With Ease
Show all investments...

Todd Corenson
Angel · Los Gatos, California, United States · 4 investments in Biotechnology startups

Todd Corenson - Founder @ Enlon

Show more...

Investment focus

  • Industry: Biotechnology, FinTech, SaaS
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$4.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
  • HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
  • iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Bill Gates
Angel · Washington, District of Columbia, United States · 4 investments in Biotechnology startups

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Manufacturing
  • Stage:Series C, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 96
  • Lead/follow: no public data

Portfolio highlights

  • Mainspring Energy — Flexible onsite generation for data centers, utility, industrial & enterprise applications. Fuel-flexible, fast to deploy, high-efficiency, low NOx power.
  • Echodyne — Echodyne develops and manufactures meta-materials-based radar technologies. The company combines the patented technology of metamaterials with powerful software to create a radar sensor with unprecedented performance at commercial price points. Echodyne's patented technology and powerful software create a high-performance radar platform thatproduces security and machine autonomy solutions for government, defense, and industry.Echodyne was founded in 2014 and is headquartered in Kirkland, Washington.
  • TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
Show all investments...

Xavier Niel
Angel · Paris, Ile-de-France, France · 4 investments in Biotechnology startups

Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 123
  • Lead/follow: no public data

Portfolio highlights

  • Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
  • Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
  • Mobile Club — Mobile.club is a smartphone rental without obligation.
Show all investments...

Martin Chavez
Angel · New York, New York, United States · 4 investments in Biotechnology startups

Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985.

Show more...

Investment focus

  • Industry: Health Care, Machine Learning, Biotechnology
  • Stage:Series A, Seed, Private Equity
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Lead/follow: no public data

Portfolio highlights

  • Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
  • Samaya AI — Expert AI Agents for Financial Services
  • VMind AI — VMind is a frontier technology company building artificial general intelligence (AGI).
Show all investments...

Tom Williams
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Tom Williams

Show more...

Investment focus

  • Industry: Software, Health Care, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 76
  • Lead/follow: no public data

Portfolio highlights

  • Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
  • Delphia — Invest with your data, not your money.
  • North One — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 4 investments in Biotechnology startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Daren Cotter
Angel · Minneapolis, Minnesota, United States · 4 investments in Biotechnology startups, 6 in the past 12 months

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 79
  • Lead/follow: no public data

Portfolio highlights

  • Bonsai — Bonsai is the first-party marketing intelligence platform that automates profitable growth. Trust your marketing data, make confident decisions, drive revenue.
  • Franzy — Franzy is the "Zillow for franchising"—a smarter, more transparent way to find, compare, and finance franchise opportunities. We match aspiring entrepreneurs with the right franchise brands based on their goals, experience, and budget, making the path to business ownership simpler, faster, and more accessible.
  • Bonsai Data Solutions — Bonsai is the first-party marketing intelligence platform that automates profitable growth. Trust your marketing data, make confident decisions, drive revenue.
Show all investments...

T. Chen Fong
Angel · Calgary, Alberta, Canada · 4 investments in Biotechnology startups

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Canada, Singapore, United States

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
  • SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
  • EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.
Show all investments...

Penny Schiffer
Angel · 4 investments in Biotechnology startups

Penny Schiffer - CEO & Co-founder @ Raized.ai

Show more...

Investment focus

  • Industry: Health Care, Medical, Finance
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 34
  • Lead/follow: no public data

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
  • Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Show all investments...

Annie Vereecken
Angel · 4 investments in Biotechnology startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

David Beyer
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 35
  • Round size: Seed $1.2M–$4M; Angel $500k–$2.2M; Series A $2.7M–$23M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Airtable — 500,000+ brands use Airtable to enable real-time collaboration, automate repetitive tasks & manual work, and streamline business processes in minutes. Join them.
  • Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
  • Skycatch — Industry-Leading Drone Automation and AI-Driven Data Analysis Platform Transforming Global Industries
Show all investments...

Biotechnology Angel investor funding at a glance

Stats across 1.6k deals from 1.7k investors.

1.7k
investors
in Biotechnology startups
1.6k
deals
in Biotechnology startups
$6.5M
median round
in Biotechnology startups
12%
lead investors
lead at least one round
35%
Seed
most common funding stage

Access all 1742 angel investors in Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1742 angel investors investing in Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists